Skin cancer – HealthQuill

Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or melanoma.

Moderna, Merck’s skin cancer vaccine shows rise in survival rates

Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or.

by HealthQuill
June 4, 2024
0 Comments

The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.

Drugs Medical Pharma

Merck discontinues trial for combo cancer drug for melanoma

HQ Team May 13, 2024: Merck has discontinued another cancer experimental immunotherapy treatment in patients with a severe form of melanoma due to.

by HealthQuill
May 13, 2024
0 Comments

Iovance Biotherapeutics, a San Carlos, California-based company, has been given the nod for its T-cell therapy to treat melanoma — the most serious form of skin cancer — in adult patients.

Drugs Health Pharma

New drug to fight skin cancer gets nod from US drug regulator

HQ Team February 17, 2024: Iovance Biotherapeutics, a San Carlos, California-based company, has been given the nod for its T-cell therapy to treat.

by HealthQuill
February 17, 2024
0 Comments

The FDA has approved US-based DermaSensor Inc.'s handheld wireless skin cancer detection device that is powered by artificial intelligence technology.

Drugs Medical Pharma

FDA green lights DermaSensor’s skin cancer detection device in the US

HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.

by HealthQuill
January 18, 2024
0 Comments

Drugs Medical Pharma

Moderna’s melanoma vaccine shows promise in clinical trials

HQ Team December 23, 2023: Moderna unveiled a skin cancer vaccine that demonstrated promising results in recent clinical trials. The vaccine, administered in.